About the ACS IRG
The American Cancer Society Institutional Research Grants (ACS IRG) is awarded to junior faculty to pursue basic, pre-clinical, clinical and cancer-control research studies. These funds are intended for new investigators who are within six years of their first academic appointment, and to provide new investigators with necessary resources to more rapidly develop their research, generate pilot data and publish their results, all of which enhances their ability to compete for national-level funding.
Award details
- Awards of up to $40,000/year are provided for up to five junior faculty each year
- Awardees must have an established mentor/mentoring team in place
Application requirements
- Applicants are required to consult with a biostatistician as part of the proposal to assist with design and statistical methods if applicable. For biostatistical support, please contact Dr. Roy Sabo at roy.sabo@vcuhealth.org, or visit the MCC Biostatistics Shared Resource.
- Applicants are also encouraged to engage a Community Champion in the project. Please contact Dr. Maria Thomson at cancerchamps@vcu.edu to set an appointment for your consultation.
Upcoming deadlines and award dates
2022 ACS IRG applications are no longer being accepted. Stay tuned for more details on 2023 Letters of Intent.
Questions?
Contact Alex Haynes at haynesa4@vcu.edu or (305) 915-4200.
| Awardees | Title of Project | Department |
|---|---|---|
| Eddie Chae | Regulation of innate lymphoid cell mediated anti-tumor immunity by the Wnt system | Microbiology and Immunology |
| Elizabeth Krieger | Understanding donor lymphocyte infusion response | Pediatric Hematology and Oncology |
| Jie Shen | The role of allostatic load and biological aging in the association of neighborhood disadvantage with breast cancer outcomes and racial disparity | Epidemiology |
| Kathy Tossas | Role of the vaginal microbiome on human papilloma virus carcinogenicity- Implications for racial disparities | Health Behavior and Policy |
| Teresa Salgado | Preferences for Chemotherapy Discontinuation due to Chemotherapy Induced Peripheral Neuropathy Among Patients with Metastatic Breast Cancer | Pharmacotherapy and Outcomes Science |
| Awardees | Title of Project | Department |
|---|---|---|
| Inho Joh | Heterochromatin-mediated mechanosensing for tumor dormancy | Physics |
| Xuewei Wang | Potassium ionophore-based lipid nanoparticles for treatment of solid tumors with necrosis | Chemistry |
| Chunqing Guo | Blockade of scavenger receptor a to enhance cancer immunotherapy and radiotherapy | Human and Molecular Genetics |
| Rebecca Martin | ADAM17 and membrane TNF on macrophages regulates ST2+ T regulatory cells that limit obesity-induced inflammation in mice | Microbiology and Immunology |
| Sunny Jung Kim | Cannabis use and acceptance among cancer survivors and care providers | Health Behavior and Policy |